- A large new study determined that the adverse reactions of depression drugs differ considerably by drug.
- Some drugs resulted in reduced body weight, whereas different drugs resulted in added mass.
- Pulse rate and BP additionally varied significantly between medications.
- Those suffering from persistent, intense, or troubling adverse reactions must consult a physician.
New research has revealed that antidepressant unwanted effects may be more diverse than once assumed.
This comprehensive investigation, released on the 21st of October, assessed the impact of depression treatments on more than 58,000 participants within the first two months of starting medication.
The researchers studied 151 investigations of 30 medications typically prescribed to manage depression. While not every patient experiences adverse reactions, some of the most frequent recorded in the research were changes in body weight, arterial pressure, and metabolic indicators.
Researchers observed notable differences across antidepressant drugs. For instance, an two-month course of one medication was linked to an typical weight loss of around 2.4 kg (approximately 5.3 pounds), whereas another drug individuals increased close to 2 kg in the identical timeframe.
Furthermore, marked changes in cardiovascular activity: fluvoxamine was likely to decrease pulse rate, whereas nortriptyline elevated it, causing a gap of around 21 heartbeats per minute across the both treatments. BP differed too, with an 11 millimeters of mercury disparity seen across nortriptyline and doxepin.
Antidepressant Medication Adverse Reactions Comprise a Broad Array
Clinical specialists commented that the research's findings aren't new or startling to psychiatrists.
"It has long been understood that various antidepressant medications vary in their impacts on body weight, blood pressure, and additional metabolic measures," one specialist stated.
"Nonetheless, what is significant about this study is the rigorous, comparative assessment of these disparities among a extensive array of bodily measurements using data from more than 58,000 subjects," the professional added.
The study offers strong proof of the extent of side effects, some of which are more frequent than others. Common antidepressant side effects may comprise:
- digestive issues (sickness, bowel issues, blockage)
- sexual problems (decreased libido, anorgasmia)
- mass variations (increase or reduction, depending on the medication)
- rest issues (sleeplessness or sedation)
- dry mouth, perspiration, migraine
Meanwhile, rarer but therapeutically relevant side effects may encompass:
- rises in BP or pulse rate (especially with SNRIs and certain tricyclics)
- low sodium (particularly in elderly individuals, with selective serotonin reuptake inhibitors and SNRIs)
- liver enzyme elevations
- QTc prolongation (chance of irregular heartbeat, notably with citalopram and certain tricyclics)
- diminished feelings or apathy
"An important point to consider in this context is that there are various varying types of depression drugs, which lead to the varying adverse drug reactions," a different specialist commented.
"Additionally, antidepressant medications can affect each patient distinctly, and negative effects can vary depending on the exact pharmaceutical, dosage, and patient considerations including metabolism or simultaneous health issues."
While several side effects, including fluctuations in rest, hunger, or vitality, are fairly frequent and frequently get better over time, different reactions may be less typical or more persistent.
Consult with Your Healthcare Provider About Intense Unwanted Effects
Antidepressant adverse reactions may differ in severity, which could justify a adjustment in your drug.
"A change in antidepressant medication may be appropriate if the individual experiences ongoing or unbearable side effects that don't get better with time or supportive care," one professional said.
"Moreover, if there is an appearance of recent health problems that may be worsened by the present treatment, for instance hypertension, arrhythmia, or substantial mass addition."
Patients may additionally contemplate talking with your doctor concerning any lack of significant improvement in low mood or anxiety-related indicators subsequent to an adequate testing period. The appropriate trial period is usually 4–8 weeks duration at a treatment dosage.
Individual preference is also significant. Some patients may prefer to avoid particular unwanted effects, including sexual dysfunction or {weight gain|increased body weight|mass addition
